Fujifilm Corp. said its influenza medicine Avigan is being given to an Ebola patient at a French hospital along with another experimental drug, the latest treatments to be deployed in the global push to curtail the deadly virus.
The French National Agency for Medicines and Health Products Safety asked for the drug and the female patient has been given the combination since Sept. 19, the Japanese company said in a statement Friday.
More than 6,200 people have been infected and 2,900 have died in the ongoing Ebola outbreak in West Africa, and the virus could sicken more than 1.4 million people by January under a worst-case scenario projected by the U.S. Centers for Disease Control and Prevention.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.